Expression of interleukin 4 receptors in bronchial asthma patients who underwent specific immunotherapy

Annals of Allergy, Asthma and Immunology

Volumn 93, Issue 1, 2004, Pages 68-75

  Kowal, Krzysztof ^a   Osada, Joanna ^a   Zukowski, Sebastian ^a   Dabrowska, Milena ^a   DuBuske, Lawrence ^b,c   Bodzenta Lukaszyk, Anna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Immunology Research Institute of New England   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CD14 ANTIGEN; CD36 ANTIGEN; INTERLEUKIN 4 RECEPTOR; MONOCLONAL ANTIBODY; STEROID; IMMUNOGLOBULIN E;

ANTIGEN EXPRESSION; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; IMMUNOTHERAPY; MONOCYTE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UPREGULATION; BLOOD; IMMUNOLOGY;

ANTIGENS, CD14; ANTIGENS, CD36; ASTHMA; HUMANS; IMMUNOGLOBULIN E; IMMUNOTHERAPY; RECEPTORS, INTERLEUKIN-4;

EID: 3843133045     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61449-4     Document Type: Article

References (38)

1. Corry DB, Kheradmand F. Induction and regulation of the IgE response. Nature. 1999;402:B18-B23.
2. van der Pouw Kraan TC, Boeije LC, de Groot ER, et al. Reduced production of IL-12 and IL-12-dependent IFN-γ release in patients with allergic asthma. J Immunol. 1997;158:5560-5565.
3. Higashi N, Gesser B, Kawana S, Thestrup-Pedersen K. Expression of IL-18 mRNA and secretion of IL-18 are reduced in monocytes from patients with atopic dermatitis. J Allergy Clin Immunol. 2001;108:607-614.
4. Kohno K, Kataoka J, Ohtsuki T, et al. IFN-γ inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol. 1997;158:1541-1550.
5. Bonder CS, Finlay-Jones JJ, Hart PH. Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production: role of a functional interleukin-2 receptor γ-chain. Immunology. 1999;96:529-536.
6. Chanez P, Vignola AM, Paul-Eugene N, et al. Modulation by interleukin-4 of cytokine release from mononuclear phagocytes in asthma. J Allergy Clin Immunol. 1994;94:997-1005.
7. Osnes LT, Westvik AB, Joo GB, Okkenhaug C, Kierulf P. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13. Cytokine. 1996;8:822-827.
8. de Waal Malefyt R, Figdor CG, Huijbens R, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol. 1993;151:6370-6381.
9. Montaner LJ, da Silva RP, Sun J, et al. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-γ or IL-10. J Immunol. 1999;162:4606-4613.
10. Williams J, Johnson S, Mascali JJ, Smith H, Rosenwasser LJ, Borish L. Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. J Immunol. 1992;149:2823-2829.
11. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of interleukin 4 receptor. Proc Natl Acad Sci USA. 1996;93:497-501.
12. Carballido JM, Schols D, Namikawa R, et al. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice: inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist. J Immunol. 1995;155:4162-4170.
13. Mosley B, Beckmann MP, March CJ, et al. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell. 1989;59:335-348.
14. Chilton PM, Fernandez-Botran R. Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4. J Immunol. 1993;151:5907-5917.
15. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin- 13: central mediator of allergic asthma. Science. 1998;282:2258-2261.
16. Gavett SH, O'Hearn DJ, Karp CL, et al. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol. 1997;272:L253-L261.
17. Howard TD, Koppelman GH, Xu J, et al. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet. 2002;70:230-236.
18. Peng Z, Naclerio RM, Norman PS, Adkinson NF Jr. Quantitative IgE and IgG subclass responses during and after long-term ragweed immunotherapy. J Allergy Clin Immunol. 1992;89:519-529.
19. Lichtenstein LM, Ishizaka K, Norman PS, Sobotka AK, Hill BM. IgE antibody measurement in ragweed hay fever: relationship to clinical severity and the results of immunotherapy. J Clin Invest. 1973;52:472-482.
20. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med. 1993;178:2123-2130.
21. Kuna P, Alam R, Kuzminska B, Rozniecki J. The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind placebo-controlled randomized study. J Allergy Clin Immunol. 1989;83:816-824.
22. Varney VA, Hamid QA, Gaga M, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest. 1993;92:644-651.
23. Lichtenstein LM, Norman PS, Winkenwerder WL. Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever. Am J Med. 1968;44:514-524.
24. Lichtenstein LM, Norman PS, Winkenwerder WL, et al. In vitro studies of human ragweed allergy: changes in cellular and humoral activity associated with specific desensitization. J Clin Invest. 1966;45:1126-1136.
25. Pruzansky JJ, Patterson R. Histamine release from leukocytes of hypersensitive individuals, II: reduced sensitivity of leukocytes after injection therapy. J Allergy. 1967;39:44-50.
26. Chyrek-Borowska S, Kuczewska B, Rogalewska A, Hofman J. Immunologic histamine release from isolated human basophils during specific immunotherapy. Agents Actions. 1986;18:176-177.
27. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol. 1997;99:254-260.
28. Grzela K, Grzela T, Lazarczyk M, et al. Influence of allergen-specific immunotherapy on IL-4-dependent IL- 12 production by monocytes. Int J Mol Med. 2002;10:481-484.
29. Wang JY, Ley HY, Hsieh KH. The effect of immunotherapy on interleukin-1 and tumor necrosis factor production of monocytes in asthmatic children. J Asthma. 1992;29:193-201.
30. Liu E, Tu W, Law HK, Lau YL. Changes of CD14 and CD1a expression in response to IL-4 and granulocyte-macrophage colony-stimulating factor are different in cord blood and adult blood monocytes. Pediatr Res. 2001;50:184-189.
31. Huang JT, Welch JS, Ricote M, et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature. 1999;400:378-382.
32. Ryan G, Dolovich MB, Roberts RS, et al. Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis. 1981;123:195-199.
33. Cockcroft DW, Ruffin RE, Frith PA, et al. Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis. 1979;120:1053-1058.
34. Renz H, Domenico J, Gelfand EW. IL-4 dependent up-regulation of IL-4 receptor expression in murine T and B cells. J Immunol. 1991;146:3049-3055.
35. Grzela K, Grzela T, Lazarczyk D, et al. CD124 on monocytes in grass pollen allergy. Allergy. 2001;57:254-255.
36. Siegmund R, Vogelsang H, Machnik A, Hermann D. Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy. J Allergy Clin Immunol. 2000;106:1190-1195.
37. Ohmori Y, Hamilton TA. Interleukin-4/STAT6 represses STATI and NF-κB-dependent transcription through distinct mechanisms. J Biol Chem. 2000;275:38095-38103.
38. 2 inhibits IL-10 and IL-12 production by macrophages. Biochem Biophys Res Commun. 2001;283:344-346.